World Of Taxonomy
73475-1221Level 3

VYVGART Hytrulo (efgartigimod alfa and hyaluronidase (human recombinant))

**Product type:** Human Prescription Drug

**Active ingredient:** EFGARTIGIMOD ALFA; HYALURONIDASE (HUMAN RECOMBINANT)

**Strength:** 200; 2000 mg/mL; U/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** argenx US

**Marketing category:** BLA (BLA761304)

**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS], Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]

GET/api/v1/systems/ndc_fda/nodes/73475-1221
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.

73475-1221 - VYVGART Hytrulo (efgartigimod alfa and hyaluronidase (human recombinant)) - NDC - World Of Taxonomy | World Of Taxonomy